Successful and Safe Reinstitution of Chemotherapy for Pancreatic Cancer after COVID-19

Cancer patients are regarded as highly vulnerable to severe acute respiratory syndrome coronavirus (SARS-CoV)-2. However, little is known regarding how cancer treatments should be restarted for cancer patients after coronavirus disease (COVID)-19. We herein report a pancreatic cancer case in which c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Kazumasa, Kitamura, Katsuya, Hirai, Yuji, Nutahara, Daisuke, Nakamura, Hironori, Taira, Junichi, Matsue, Yubu, Abe, Masakazu, Kikuchi, Miho, Itoi, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872796/
https://www.ncbi.nlm.nih.gov/pubmed/33229812
http://dx.doi.org/10.2169/internalmedicine.6294-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872796/
https://www.ncbi.nlm.nih.gov/pubmed/33229812
http://dx.doi.org/10.2169/internalmedicine.6294-20

Ejemplares similares